Balance Sheet Data

Halozyme Therapeutics, Inc. (HALO)

$ 32.17
-0.71 (-2.16%)

Year
A/P
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
Total Cash 204.98469.21354.53421.26368.01618.96819.181,084.181,434.891,899.06
Total Cash (%)
Account Receivables 15.6822.1330.0159.4497.7373.8797.76129.39171.24226.64
Account Receivables (%)
Inventories 14.625.1522.6329.3660.7545.4560.1679.62105.37139.46
Inventories (%)
Accounts Payable 3.587.954.086.431.938.2410.9114.4419.1125.29
Accounts Payable (%)
Capital Expenditure -3.14-1.35-4.66-4.04-2.50-6.11-8.09-10.71-14.17-18.76
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.